Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9393256 Methods for treating HCV

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
May 1, 2013
Date of Patent
July 19, 2016
Patent Application Number
13875252
Patent Citations Received
‌
US Patent 12012431 Methods of preparing 1′-cyano nucleosides
0
‌
US Patent 11939347 1′-cyano nucleoside analogs and uses thereof
0
‌
US Patent 11975017 Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections
0
‌
US Patent 11975012 Remdesivir treatment methods
0
‌
US Patent 11660307 Methods for treating SARS CoV-2 infections
0
‌
US Patent 11701372 Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs
0
‌
US Patent 11707479 Combination formulation of two antiviral compounds
0
‌
US Patent 11780844 Compounds and methods for treatment of viral infections
‌
US Patent 11851438 1′-cyano nucleoside analogs and methods for treatment of viral infections
0
‌
US Patent 11903953 Remdesivir treatment methods
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9393256
Patent Primary Examiner
‌
Jeffrey S Lundgren

Find more entities like US Patent 9393256 Methods for treating HCV

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo